Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	gamma-catenin binding	DSC3 PTPRJ PTPRT	1.48e-05	12	83	3	GO:0045295
GeneOntologyMolecularFunction	calcium ion binding	CACNA1B FAT4 CELSR1 FAT2 DST DSC3 UMODL1 PLCH2 PCDHB12 DCHS1 LRP2 PPEF2	5.98e-05	749	83	12	GO:0005509
GeneOntologyMolecularFunction	beta-catenin binding	PTPRJ DCHS1 TBL1XR1 BTRC PTPRT	1.44e-04	120	83	5	GO:0008013
GeneOntologyMolecularFunction	protein phosphorylated amino acid binding	LCK BTRC STAP1 FBXW7	1.95e-04	69	83	4	GO:0045309
GeneOntologyMolecularFunction	nerve growth factor binding	SORT1 A2M	4.70e-04	8	83	2	GO:0048406
GeneOntologyMolecularFunction	growth factor binding	SORT1 GPC1 A2M CD109 LRP2	4.85e-04	156	83	5	GO:0019838
GeneOntologyMolecularFunction	delta-catenin binding	PTPRJ PTPRT	9.16e-04	11	83	2	GO:0070097
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PRTG FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1 PTPRT	7.90e-07	187	82	8	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	PRTG FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1 SLITRK3 PTPRT	4.22e-06	313	82	9	GO:0098742
GeneOntologyBiologicalProcess	establishment of planar polarity	FAT4 CELSR1 DCHS1 CPLANE1	2.79e-05	44	82	4	GO:0001736
GeneOntologyBiologicalProcess	establishment of tissue polarity	FAT4 CELSR1 DCHS1 CPLANE1	3.05e-05	45	82	4	GO:0007164
GeneOntologyBiologicalProcess	cell-cell adhesion	CFH VMP1 PRTG FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1 COL14A1 UFL1 SLITRK3 LCK PTPRT	8.13e-05	1077	82	14	GO:0098609
GeneOntologyBiologicalProcess	condensed mesenchymal cell proliferation	FAT4 DCHS1	9.32e-05	4	82	2	GO:0072137
Domain	WD40_repeat_CS	NWD1 NWD2 EML5 TBL1Y WDR41 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	2.90e-09	164	83	10	IPR019775
Domain	-	SORT1 NWD1 NWD2 EML5 TBL1Y WDR41 ARHGEF17 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	2.64e-08	333	83	12	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	SORT1 NWD1 NWD2 EML5 TBL1Y WDR41 ARHGEF17 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	2.82e-08	335	83	12	IPR015943
Domain	WD40_repeat_dom	NWD1 NWD2 EML5 TBL1Y WDR41 ARHGEF17 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	7.99e-08	297	83	11	IPR017986
Domain	WD40	NWD1 NWD2 EML5 TBL1Y WDR41 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	3.03e-07	268	83	10	SM00320
Domain	WD40_repeat	NWD1 NWD2 EML5 TBL1Y WDR41 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	3.47e-07	272	83	10	IPR001680
Domain	WD_REPEATS_1	NWD1 NWD2 EML5 TBL1Y WDR41 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	4.24e-07	278	83	10	PS00678
Domain	WD_REPEATS_2	NWD1 NWD2 EML5 TBL1Y WDR41 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	4.39e-07	279	83	10	PS50082
Domain	WD_REPEATS_REGION	NWD1 NWD2 EML5 TBL1Y WDR41 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	4.39e-07	279	83	10	PS50294
Domain	fn3	PRTG PTPRJ UMODL1 TNN OBSL1 FSD2 COL14A1 PTPRT	6.12e-07	162	83	8	PF00041
Domain	FN3	PRTG PTPRJ UMODL1 TNN OBSL1 FSD2 COL14A1 PTPRT	1.67e-06	185	83	8	SM00060
Domain	WD40	NWD1 EML5 TBL1Y WDR41 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	2.22e-06	259	83	9	PF00400
Domain	FN3	PRTG PTPRJ UMODL1 TNN OBSL1 FSD2 COL14A1 PTPRT	2.87e-06	199	83	8	PS50853
Domain	FN3_dom	PRTG PTPRJ UMODL1 TNN OBSL1 FSD2 COL14A1 PTPRT	4.13e-06	209	83	8	IPR003961
Domain	ConA-like_dom	FAT4 CELSR1 FAT2 PTX3 CSPG4 FSD2 COL14A1 PTPRT	5.83e-06	219	83	8	IPR013320
Domain	Laminin_G	FAT4 CELSR1 FAT2 CSPG4 COL14A1	5.84e-06	58	83	5	IPR001791
Domain	Cadherin_CS	FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1	9.01e-06	109	83	6	IPR020894
Domain	CADHERIN_1	FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1	1.11e-05	113	83	6	PS00232
Domain	Cadherin	FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1	1.11e-05	113	83	6	PF00028
Domain	CADHERIN_2	FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1	1.17e-05	114	83	6	PS50268
Domain	-	FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1	1.17e-05	114	83	6	2.60.40.60
Domain	CA	FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1	1.23e-05	115	83	6	SM00112
Domain	Cadherin-like	FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1	1.29e-05	116	83	6	IPR015919
Domain	Cadherin	FAT4 CELSR1 FAT2 DSC3 PCDHB12 DCHS1	1.42e-05	118	83	6	IPR002126
Domain	LAM_G_DOMAIN	FAT4 CELSR1 FAT2 CSPG4	2.39e-05	38	83	4	PS50025
Domain	Laminin_G_2	FAT4 CELSR1 FAT2 CSPG4	2.93e-05	40	83	4	PF02210
Domain	G-protein_beta_WD-40_rep	TBL1Y WDR41 TBL1XR1 BTRC FBXW7	3.81e-05	85	83	5	IPR020472
Domain	LamG	FAT4 CELSR1 FAT2 CSPG4	4.30e-05	44	83	4	SM00282
Domain	-	FAT4 CELSR1 FAT2 PTX3 CSPG4	6.50e-05	95	83	5	2.60.120.200
Domain	EGF_CA	FAT4 CELSR1 FAT2 UMODL1 LRP2	2.12e-04	122	83	5	SM00179
Domain	EGF-like_Ca-bd_dom	FAT4 CELSR1 FAT2 UMODL1 LRP2	2.28e-04	124	83	5	IPR001881
Domain	Thiol-ester_cl	A2M CD109	5.37e-04	8	83	2	PF10569
Domain	MacrogloblnA2_thiol-ester-bond	A2M CD109	5.37e-04	8	83	2	IPR019565
Domain	MacrogloblnA2_CS	A2M CD109	5.37e-04	8	83	2	IPR019742
Domain	A2M_N_2	A2M CD109	5.37e-04	8	83	2	SM01359
Domain	-	A2M CD109	5.37e-04	8	83	2	2.60.40.690
Domain	A2M_recep	A2M CD109	5.37e-04	8	83	2	SM01361
Domain	A2M	A2M CD109	5.37e-04	8	83	2	SM01360
Domain	EGF_3	FAT4 CELSR1 FAT2 UMODL1 TNN LRP2	6.27e-04	235	83	6	PS50026
Domain	EGF	FAT4 CELSR1 FAT2 UMODL1 TNN LRP2	6.27e-04	235	83	6	SM00181
Domain	Growth_fac_rcpt_	FAT4 CELSR1 UMODL1 TNN LRP2	6.55e-04	156	83	5	IPR009030
Domain	Ptc/Disp	PTCHD1 DISP1	6.88e-04	9	83	2	IPR003392
Domain	Patched	PTCHD1 DISP1	6.88e-04	9	83	2	PF02460
Domain	LisH	TBL1Y TBL1XR1	6.88e-04	9	83	2	PF08513
Domain	EGF-like_dom	FAT4 CELSR1 FAT2 UMODL1 TNN LRP2	8.47e-04	249	83	6	IPR000742
Domain	A2M_N	A2M CD109	8.58e-04	10	83	2	PF01835
Domain	Sugar_P_trans_dom	SLC35E2A SLC35E2B	8.58e-04	10	83	2	IPR004853
Domain	A2M_N	A2M CD109	8.58e-04	10	83	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	A2M CD109	8.58e-04	10	83	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	A2M CD109	8.58e-04	10	83	2	PS00477
Domain	A2M	A2M CD109	8.58e-04	10	83	2	PF00207
Domain	A2M_N_2	A2M CD109	8.58e-04	10	83	2	IPR011625
Domain	A2M_comp	A2M CD109	8.58e-04	10	83	2	IPR011626
Domain	A2M_N_2	A2M CD109	8.58e-04	10	83	2	PF07703
Domain	A2M_recep	A2M CD109	8.58e-04	10	83	2	PF07677
Domain	A2M_comp	A2M CD109	8.58e-04	10	83	2	PF07678
Domain	TPT	SLC35E2A SLC35E2B	8.58e-04	10	83	2	PF03151
Domain	Macroglobln_a2	A2M CD109	8.58e-04	10	83	2	IPR001599
Domain	EGF_1	FAT4 CELSR1 FAT2 UMODL1 TNN LRP2	9.58e-04	255	83	6	PS00022
Domain	ASX_HYDROXYL	FAT4 CELSR1 UMODL1 LRP2	1.03e-03	100	83	4	PS00010
Domain	EGF-like_CS	FAT4 CELSR1 FAT2 UMODL1 TNN LRP2	1.08e-03	261	83	6	IPR013032
Domain	EGF_2	FAT4 CELSR1 FAT2 UMODL1 TNN LRP2	1.17e-03	265	83	6	PS01186
Domain	-	A2M CD109	1.25e-03	12	83	2	1.50.10.20
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT4 CELSR1 UMODL1 LRP2	1.28e-03	106	83	4	IPR000152
Domain	SSD	PTCHD1 DISP1	1.47e-03	13	83	2	IPR000731
Domain	SSD	PTCHD1 DISP1	1.47e-03	13	83	2	PS50156
Domain	Quinoprotein_ADH-like_supfam	NWD1 EML5 ERN1	1.69e-03	53	83	3	IPR011047
Domain	P_typ_ATPase_c	ATP9B ATP9A	1.72e-03	14	83	2	IPR032630
Domain	P-type_ATPase_N	ATP9B ATP9A	1.72e-03	14	83	2	IPR032631
Domain	P-type_ATPase_IV	ATP9B ATP9A	1.72e-03	14	83	2	IPR006539
Domain	PhoLip_ATPase_C	ATP9B ATP9A	1.72e-03	14	83	2	PF16212
Domain	PhoLip_ATPase_N	ATP9B ATP9A	1.72e-03	14	83	2	PF16209
Domain	Gal_mutarotase_SF_dom	MAN2B2 GALM	2.54e-03	17	83	2	IPR011013
Domain	-	PRTG CD3D PTPRJ UMODL1 TNN OBSL1 FSD2 COL14A1 PTPRT	2.68e-03	663	83	9	2.60.40.10
Domain	Terpenoid_cyclase/PrenylTrfase	A2M CD109	2.85e-03	18	83	2	IPR008930
Domain	-	PHOSPHO2 ATP9B ATP9A	2.90e-03	64	83	3	3.40.50.1000
Domain	Apc4_WD40_dom	NWD1 EML5	3.52e-03	20	83	2	IPR024977
Domain	ANAPC4_WD40	NWD1 EML5	3.52e-03	20	83	2	PF12894
Domain	Ig-like_fold	PRTG CD3D PTPRJ UMODL1 TNN OBSL1 FSD2 COL14A1 PTPRT	4.06e-03	706	83	9	IPR013783
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT4 FAT2 DCHS1	4.90e-07	7	85	3	16059920
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	FAT4 CELSR1 DSC3 DCHS1 PRKDC	6.64e-07	67	85	5	21875946
Pubmed	Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.	FAT4 CELSR1 DCHS1	1.17e-06	9	85	3	28705793
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	SORT1 GPC1 CFH VMP1 FAT4 CELSR1 B4GALNT1 MAN2B2 PTPRJ CSPG4 CD109 ST3GAL1 ATP9A GPR107	1.23e-06	1201	85	14	35696571
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	A2M CFH FAT2 PTPRJ TNN CSPG4 CD109	3.35e-06	257	85	7	16335952
Pubmed	Molecular genetics of successful smoking cessation: convergent genome-wide association study results.	CD109 ST3GAL1 ATP9A WDFY4 PTPRT	5.10e-06	101	85	5	18519826
Pubmed	SLC35E2 promoter mutation as a prognostic marker of esophageal squamous cell carcinoma.	SLC35E2A SLC35E2B	5.90e-06	2	85	2	35247439
Pubmed	Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation.	CFH PTX3	5.90e-06	2	85	2	19050261
Pubmed	Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration.	BTRC FBXW7	5.90e-06	2	85	2	36591289
Pubmed	Structure of the planar cell polarity cadherins Fat4 and Dachsous1.	FAT4 DCHS1	5.90e-06	2	85	2	36797229
Pubmed	Mammalian cadherins DCHS1-FAT4 affect functional cerebral architecture.	FAT4 DCHS1	5.90e-06	2	85	2	25930014
Pubmed	Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions.	FAT4 DCHS1	5.90e-06	2	85	2	25355906
Pubmed	Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis.	PRKDC SIRT3	5.90e-06	2	85	2	31185214
Pubmed	Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.	FAT4 FAT2 DCHS1	1.12e-05	18	85	3	33108146
Pubmed	C-reactive protein and pentraxin-3 binding of factor H-like protein 1 differs from complement factor H: implications for retinal inflammation.	CFH PTX3	1.77e-05	3	85	2	29374201
Pubmed	ATF4 and IRE1α inhibit DNA repair protein DNA-dependent protein kinase 1 induced by heat shock.	ERN1 PRKDC	1.77e-05	3	85	2	23001845
Pubmed	Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.	CFH PTX3	1.77e-05	3	85	2	22786770
Pubmed	Asymmetry-defective oligodendrocyte progenitors are glioma precursors.	CSPG4 PRKDC	1.77e-05	3	85	2	21907924
Pubmed	Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells.	BTRC FBXW7	3.53e-05	4	85	2	34347919
Pubmed	Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition.	CFH PTX3	3.53e-05	4	85	2	19632990
Pubmed	Defective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathy.	CD109 PRKDC	3.53e-05	4	85	2	22490868
Pubmed	Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.	PRKDC FBXW7	3.53e-05	4	85	2	20823234
Pubmed	Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.	RNF128 BTRC	3.53e-05	4	85	2	31715145
Pubmed	Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.	TBL1Y TBL1XR1	5.87e-05	5	85	2	21459324
Pubmed	Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover.	BTRC FBXW7	5.87e-05	5	85	2	20852628
Pubmed	Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development.	FAT4 DCHS1	5.87e-05	5	85	2	24056717
Pubmed	Multiple members of a third subfamily of P-type ATPases identified by genomic sequences and ESTs.	ATP9B ATP9A	5.87e-05	5	85	2	9548971
Pubmed	Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis.	B4GALNT1 ST3GAL1	5.87e-05	5	85	2	17101770
Pubmed	Stratifin Inhibits SCFFBW7 Formation and Blocks Ubiquitination of Oncoproteins during the Course of Lung Adenocarcinogenesis.	BTRC FBXW7	5.87e-05	5	85	2	30728155
Pubmed	A stress sensor, IRE1α, is required for bacterial-exotoxin-induced interleukin-1β production in tissue-resident macrophages.	B4GALNT1 ERN1	5.87e-05	5	85	2	38520688
Pubmed	Structure of the MeCP2-TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders.	TBL1Y TBL1XR1	8.80e-05	6	85	2	28348241
Pubmed	Detection of sequential polyubiquitylation on a millisecond timescale.	BTRC FBXW7	8.80e-05	6	85	2	19956254
Pubmed	HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.	CD3D LCK	8.80e-05	6	85	2	7774645
Pubmed	Mammalian Fat and Dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex.	FAT4 DCHS1	8.80e-05	6	85	2	19506035
Pubmed	Characterization of a mouse gene (Fbxw6) that encodes a homologue of Caenorhabditis elegans SEL-10.	BTRC FBXW7	1.23e-04	7	85	2	11735228
Pubmed	Identification of substrates for F-box proteins.	BTRC FBXW7	1.23e-04	7	85	2	16338364
Pubmed	Cdh1, a substrate-recruiting component of anaphase-promoting complex/cyclosome (APC/C) ubiquitin E3 ligase, specifically interacts with phosphatase and tensin homolog (PTEN) and promotes its removal from chromatin.	BTRC FBXW7	1.23e-04	7	85	2	24811168
Pubmed	Zbtb7c is a molecular 'off' and 'on' switch of Mmp gene transcription.	TBL1Y TBL1XR1	1.23e-04	7	85	2	27646874
Pubmed	ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4.	BTRC FBXW7	1.23e-04	7	85	2	22307056
Pubmed	Dchs1-Fat4 regulation of polarized cell behaviours during skeletal morphogenesis.	FAT4 DCHS1	1.23e-04	7	85	2	27145737
Pubmed	The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor.	TBL1Y TBL1XR1	1.23e-04	7	85	2	15695367
Pubmed	LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity.	BTRC FBXW7	1.64e-04	8	85	2	31152129
Pubmed	Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors.	BTRC FBXW7	1.64e-04	8	85	2	26474281
Pubmed	Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.	TBL1Y TBL1XR1	1.64e-04	8	85	2	23770565
Pubmed	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	TBL1Y TBL1XR1	1.64e-04	8	85	2	16127449
Pubmed	BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.	BTRC FBXW7	1.64e-04	8	85	2	20558726
Pubmed	NEDD8 nucleates a multivalent cullin-RING-UBE2D ubiquitin ligation assembly.	BTRC FBXW7	1.64e-04	8	85	2	32051583
Pubmed	Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins.	BTRC FBXW7	1.64e-04	8	85	2	23453757
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	GPC1 A2M CACNA1B NWD2 UFL1 TBL1XR1 BTRC	1.67e-04	475	85	7	31040226
Pubmed	DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy.	BTRC FBXW7	2.10e-04	9	85	2	22017876
Pubmed	FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.	CFH PTX3	2.10e-04	9	85	2	28533443
Pubmed	SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation.	BTRC FBXW7	2.10e-04	9	85	2	36828627
Pubmed	Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.	SORT1 NAA25 CYP17A1	2.25e-04	48	85	3	24262325
Pubmed	Isolation of novel mouse genes that were differentially expressed in W/W(V) mouse fundus.	TNN SLC39A4	2.62e-04	10	85	2	15065000
Pubmed	Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.	BTRC FBXW7	2.62e-04	10	85	2	18765672
Pubmed	Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening.	ERN1 PRKDC	2.62e-04	10	85	2	25495526
Pubmed	Real-time resolution of point mutations that cause phenovariance in mice.	PRKDC LCK	2.62e-04	10	85	2	25605905
Pubmed	The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease.	ATP9B ATP9A	2.62e-04	10	85	2	15919184
Pubmed	A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors.	TBL1Y TBL1XR1	2.62e-04	10	85	2	14980219
Pubmed	Robust cullin-RING ligase function is established by a multiplicity of poly-ubiquitylation pathways.	BTRC FBXW7	2.62e-04	10	85	2	31868589
Pubmed	DNA damage-induced activation of ATM promotes β-TRCP-mediated ARID1A ubiquitination and destruction in gastric cancer cells.	BTRC FBXW7	2.62e-04	10	85	2	31210753
Pubmed	Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage.	BTRC FBXW7	2.62e-04	10	85	2	14603323
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	A2M FKBP15 PRKDC TBL1XR1	3.07e-04	131	85	4	34551306
Pubmed	Fbxo45 inhibits calcium-sensitive proteolysis of N-cadherin and promotes neuronal differentiation.	BTRC FBXW7	3.20e-04	11	85	2	25143387
Pubmed	Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation.	FAT4 DCHS1	3.20e-04	11	85	2	26114487
Pubmed	Dchs1-Fat4 regulation of osteogenic differentiation in mouse.	FAT4 DCHS1	3.20e-04	11	85	2	31358536
Pubmed	Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP.	BTRC FBXW7	3.20e-04	11	85	2	22975506
Pubmed	Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.	SLC35E2A PLCH2 SLC35E2B	3.56e-04	56	85	3	9455484
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	CFH MAN2B2 PTX3 CD109 COL14A1	3.65e-04	248	85	5	24006456
Pubmed	Regulation of neuronal migration by Dchs1-Fat4 planar cell polarity.	FAT4 DCHS1	3.83e-04	12	85	2	24998526
Pubmed	Follistatin regulates the specification of the apical cochlea responsible for low-frequency hearing in mammals.	A2M SLITRK3	3.83e-04	12	85	2	36577057
Pubmed	Control of chromosome stability by the beta-TrCP-REST-Mad2 axis.	BTRC FBXW7	3.83e-04	12	85	2	18354482
Pubmed	HIV Nef: role in pathogenesis and viral fitness.	CD3D LCK	3.83e-04	12	85	2	18473783
Pubmed	ATP9B, a P4-ATPase (a putative aminophospholipid translocase), localizes to the trans-Golgi network in a CDC50 protein-independent manner.	ATP9B ATP9A	3.83e-04	12	85	2	21914794
Pubmed	Towards Functional Annotation of the Preimplantation Transcriptome: An RNAi Screen in Mammalian Embryos.	SLC35E2A SLC35E2B TBL1XR1	3.94e-04	58	85	3	27869233
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	OR2K2 FAT4 SLC38A10 DST PCDHB12 LRP2 PRKDC ARHGEF17	4.45e-04	736	85	8	29676528
Pubmed	HIV-1 Nef and T-cell activation: a history of contradictions.	CD3D LCK	4.52e-04	13	85	2	24187576
Pubmed	Differential expression of putative transbilayer amphipath transporters.	ATP9B ATP9A	4.52e-04	13	85	2	11015572
Pubmed	Cand1-Mediated Adaptive Exchange Mechanism Enables Variation in F-Box Protein Expression.	BTRC FBXW7	4.52e-04	13	85	2	29499133
Pubmed	TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance.	BTRC FBXW7	4.52e-04	13	85	2	33962073
Pubmed	WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins.	BTRC FBXW7	5.27e-04	14	85	2	21070969
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	FKBP15 FAT2 EML5 ATP9B	5.39e-04	152	85	4	34299191
Pubmed	Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.	PTPRJ PRKDC LCK TBL1XR1 DCAF7	5.93e-04	276	85	5	28319085
Pubmed	Phosphorylation of thyroid hormone receptor-associated nuclear receptor corepressor holocomplex by the DNA-dependent protein kinase enhances its histone deacetylase activity.	PRKDC TBL1XR1	6.07e-04	15	85	2	17242407
Pubmed	Molecular cloning of murine STAP-1, the stem-cell-specific adaptor protein containing PH and SH2 domains.	LCK STAP1	6.07e-04	15	85	2	10679268
Pubmed	Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.	BTRC FBXW7	6.93e-04	16	85	2	22388891
Pubmed	SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.	BTRC FBXW7	6.93e-04	16	85	2	29891922
Pubmed	Fat4-Dchs1 signalling controls cell proliferation in developing vertebrae.	FAT4 DCHS1	6.93e-04	16	85	2	27381226
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	CELSR1 FAT2 PCDHB12	7.44e-04	72	85	3	10380929
Pubmed	A perivascular niche for multipotent progenitors in the fetal testis.	CYP17A1 CSPG4	7.84e-04	17	85	2	30375389
Pubmed	Natural selection on the olfactory receptor gene family in humans and chimpanzees.	OR8J2 OR6M1	7.84e-04	17	85	2	12908129
Pubmed	Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development.	FAT4 DCHS1	7.84e-04	17	85	2	32155439
Pubmed	HIV-1 accessory proteins--ensuring viral survival in a hostile environment.	CD3D BTRC	7.84e-04	17	85	2	18541215
Pubmed	Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease.	FAT4 BABAM1	7.84e-04	17	85	2	22153077
Pubmed	PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth.	BTRC FBXW7	8.80e-04	18	85	2	28614300
Pubmed	Comparison of expression patterns between CREB family transcription factor OASIS and proteoglycan core protein genes during murine tooth development.	GPC1 CSPG4	8.80e-04	18	85	2	12684764
Pubmed	Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.	CD3D PLCH2	8.80e-04	18	85	2	1979339
Pubmed	M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.	BTRC FBXW7	8.80e-04	18	85	2	15070733
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	CELSR1 FAT2 PCDHB12	9.04e-04	77	85	3	10835267
Pubmed	Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun.	CSPG4 FBXW7	9.83e-04	19	85	2	20935640
Interaction	RYK interactions	PRTG FAT4 CELSR1 DST DSC3 CSPG4 DCHS1 PRKDC	2.89e-06	212	84	8	int:RYK
GeneFamily	WD repeat domain containing	NWD1 EML5 TBL1Y WDR41 TBL1XR1 WDFY4 BTRC FBXW7 DCAF7	5.04e-07	262	67	9	362
GeneFamily	Fibronectin type III domain containing	PRTG PTPRJ TNN FSD2 COL14A1 PTPRT	2.79e-05	160	67	6	555
GeneFamily	Cadherin related	FAT4 FAT2 DCHS1	3.19e-05	17	67	3	24
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	A2M CD109	4.79e-04	9	67	2	1234
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	BTRC FBXW7	7.28e-04	11	67	2	559
GeneFamily	ATPase phospholipid transporting	ATP9B ATP9A	1.38e-03	15	67	2	1210
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRJ PTPRT	2.71e-03	21	67	2	813
GeneFamily	Calcium voltage-gated channel subunits	CACNA1B CACNG6	4.15e-03	26	67	2	253
ToppCell	Posterior_cortex-Macroglia-ASTROCYTE-Gja1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	A2M CELSR1 NWD1 PTX3 FSD2 GRIN2C	7.21e-08	112	84	6	e30cd0b7b755c63081bbeed4e1a884b6640d34f8
ToppCell	Posterior_cortex-Macroglia-ASTROCYTE\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	A2M CELSR1 NWD1 PTX3 FSD2 GRIN2C	7.21e-08	112	84	6	1c0bcc6c972c50a9d950cd56b65efb8d778ec25a
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPC1 CFH CELSR1 FAT2 DSC3 PLCH2 PTPRT	9.44e-08	197	84	7	107cb153ea7fc74bbd244dbb9d0499c0a8506724
ToppCell	COVID-19_Severe-NK_CD56bright\|COVID-19_Severe / disease group, cell group and cell class	FAT4 NWD1 CYP17A1 PLCH2 FSD2 LCK	5.74e-07	159	84	6	9e2067f0d76769717f7048dab505fadd36bbb83e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M CFH CD3D GALM ERN1 LCK	1.15e-06	179	84	6	b0585a8e596c3d8e434af943e65207fa5877600d
ToppCell	Epithelial-basal_cell\|World / Lineage, Cell type, age group and donor	CFH CELSR1 FAT2 NWD1 DSC3 PLCH2	1.15e-06	179	84	6	d9be6647ec7b22747dc00dce4ea307b6af412dfa
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M CFH CD3D GALM ERN1 LCK	1.48e-06	187	84	6	f1ba41f2ec703251a81c46e08d45e70210f298e7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFH SFMBT1 CD3D GALM ERN1 LCK	1.52e-06	188	84	6	3e3055dacc05a932f2beb114babf1dc76994e1af
ToppCell	COPD-Lymphoid-T_Cytotoxic\|Lymphoid / Disease state, Lineage and Cell class	A2M CD3D GALM PTPRJ ST3GAL1 LCK	1.62e-06	190	84	6	10bece40d980d37a01dae8ce887655bf9f93040c
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 FAT2 DSC3 PLCH2 CSPG4 CD109	1.67e-06	191	84	6	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	A2M CFH DST CSPG4 PCDHB12 COL14A1	1.67e-06	191	84	6	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M CFH CD3D GALM ERN1 LCK	1.67e-06	191	84	6	b9ef6d82b86271b7e0875a399bb9aae84ef5bad3
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	A2M CFH DST CSPG4 PCDHB12 COL14A1	1.67e-06	191	84	6	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M CFH CD3D GALM ERN1 LCK	1.67e-06	191	84	6	4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M CFH PTX3 BTBD18 COL14A1 XPNPEP2	1.72e-06	192	84	6	2143e1fad2e88b90d668e12af37b2092d379090f
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	FAT2 CYP17A1 CD109 XPNPEP2 OPN1SW	1.76e-06	106	84	5	7079111add27d7b3411dfe739280d62dc256a174
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	FAT2 CYP17A1 CD109 XPNPEP2 OPN1SW	1.76e-06	106	84	5	a6334b67be05f78145b57271b7959471b80bd67f
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	A2M FAT4 DST CSPG4 PCDHB12 COL14A1	1.83e-06	194	84	6	8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPC1 CFH FAT2 DSC3 PLCH2 PTPRT	1.88e-06	195	84	6	6c9c58322c1df891bb4bab56dacb542c8777bb7d
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GPC1 CFH CELSR1 FAT2 DSC3 PLCH2	1.94e-06	196	84	6	c5adab88140a465698abcbedc6505a43cae7bfd1
ToppCell	COPD-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	SFMBT1 VMP1 CD3D GALM ERN1 ST3GAL1	1.94e-06	196	84	6	c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GPC1 A2M CFH CSPG4 ARHGEF17 RNF128	2.18e-06	200	84	6	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPC1 CELSR1 FAT2 NWD1 DSC3 PLCH2	2.18e-06	200	84	6	8827653738a931e4a4545e0c7d75be12bed40740
ToppCell	facs-Pancreas-Exocrine-24m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3D NWD2 TNN CD109 LRP2	4.79e-06	130	84	5	8c81853c806e9a0d562e00dc5e00a8fc569a854c
ToppCell	facs-Pancreas-Exocrine-24m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3D NWD2 TNN CD109 LRP2	4.79e-06	130	84	5	3041d20fe964d282d95c0312396f26bc93929056
ToppCell	facs-Pancreas-Exocrine-24m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3D NWD2 TNN CD109 LRP2	4.79e-06	130	84	5	3b6a8eaef593db73c2fad2260b9f1e15950ccb70
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CFH DMGDH B4GALNT1 DST UFL1	9.01e-06	148	84	5	f90ee6fbd71b5e0512af34867202f38409f4de38
ToppCell	Adult-Epithelial-basal_cell-D122\|Adult / Lineage, Cell type, age group and donor	CFH FAT2 NWD1 DSC3 PLCH2	1.09e-05	154	84	5	38d346402417960044ae999e61f0092b46f2b591
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3D CELSR1 GALM LCK TBL1XR1	1.44e-05	163	84	5	4af92b211d12c5b88b65bb746242cd702b545bd0
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3D CELSR1 GALM LCK TBL1XR1	1.44e-05	163	84	5	d24774e0aa612322c22fdb3b314aef275fa01d68
ToppCell	Control-Lymphocyte-T_NK-MAIT\|Control / Disease, Lineage and Cell Type	CFH PRTG CD3D ERN1 LCK	1.71e-05	169	84	5	8c2aac193a9c500f01a99a2ee530839c851b6222
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GPC1 CFH FAT2 DST DSC3	1.76e-05	170	84	5	0cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GPC1 CFH FAT2 DST DSC3	1.76e-05	170	84	5	2d880223d01bde4bf777bd6f50b7d2768489075f
ToppCell	Control-Epithelial_cells-Airway_basal\|Control / group, cell type (main and fine annotations)	CFH CELSR1 FAT2 DSC3 PLCH2	1.81e-05	171	84	5	3965ced4be6db14265a90673502fceee425837ca
ToppCell	normal-na-Lymphocytic_T-T4_em-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CFH CD3D FAT2 GALM ERN1	1.81e-05	171	84	5	61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPC1 FAT2 DST DSC3 CD109	1.86e-05	172	84	5	e9095c3dac66cf93d31f5f88364b565abacb1e2d
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	SORT1 TRANK1 PLCH2 ATP9A CREG1	1.92e-05	173	84	5	42c911ed16fabdabef063830e8407192d8bde950
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined\|B_lymphocytes / Location, Cell class and cell subclass	CD3D PLCH2 GRIN2C LCK ARHGEF17	1.97e-05	174	84	5	390bd41ef114464f3db3e0cac4e67fe7571b4c23
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CFH CD3D GALM ERN1 LCK	2.02e-05	175	84	5	cc2428150987911d0d382e8177918724aa69f85c
ToppCell	NS-moderate-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	A2M FAT4 B4GALNT1 CSPG4 DCHS1	2.02e-05	175	84	5	f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CFH CD3D GALM ERN1 LCK	2.08e-05	176	84	5	003076f1a983409ddf31b9c19e61c1facdd72566
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH CELSR1 FAT2 DSC3 PLCH2	2.14e-05	177	84	5	cbad1a23851151dbef01ea2af960e6f0944f838b
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPC1 A2M CFH FAT4 TNN	2.32e-05	180	84	5	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M CFH CD3D ERN1 LCK	2.32e-05	180	84	5	05f14cd367021891166825a8aac171227e2bcd97
ToppCell	droplet-Kidney-nan-3m-Hematologic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3D B4GALNT1 FSD2 LCK DISP1	2.38e-05	181	84	5	58d7e76dfaa818aeaef7f129c4472bf5b6563218
ToppCell	droplet-Kidney-nan-3m-Hematologic\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3D B4GALNT1 FSD2 LCK DISP1	2.38e-05	181	84	5	5d76e99bf2b5b337041efd3cd33bebbb0637b64e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	NWD1 GALM LRP2 XPNPEP2 PTPRT	2.38e-05	181	84	5	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	droplet-Kidney-nan-3m-Hematologic-leukocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3D B4GALNT1 FSD2 LCK DISP1	2.38e-05	181	84	5	970fc90e27236ee30190f1a02f418a378919c60b
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M CFH CD3D ERN1 LCK	2.44e-05	182	84	5	f30e5a21b49f30b82e2b6f1fd2daefd805a40083
ToppCell	COVID-19_Severe-Lymphoid_T/NK-MAIT\|COVID-19_Severe / Disease group, lineage and cell class	A2M CFH CD3D ERN1 LCK	2.44e-05	182	84	5	19045db5c726c06ec6e4feb4311633c8164ddb3c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	A2M CFH CD3D ERN1 LCK	2.44e-05	182	84	5	cccac9f85825f4e310b86e37ee6320769a670501
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH FAT2 DSC3 PLCH2 HMGCS2	2.44e-05	182	84	5	678eadd57e7e830fc2bf9fd35616d3badce01705
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH FAT2 DSC3 PLCH2 HMGCS2	2.44e-05	182	84	5	8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M CFH CD3D ERN1 LCK	2.44e-05	182	84	5	1444cdc4522a70a40d697ccadf54cf26d327ade0
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M CFH CD3D ERN1 LCK	2.44e-05	182	84	5	49eced222e8f90c2b59bcc7d56b62c3e703fcce5
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	GPC1 CACNA1B FAT2 B4GALNT1 DSC3	2.57e-05	184	84	5	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M CFH DST PTX3 COL14A1	2.71e-05	186	84	5	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M PTCHD1 TNN CSPG4 ARHGEF17	2.78e-05	187	84	5	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M PTCHD1 TNN CSPG4 ARHGEF17	2.78e-05	187	84	5	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M PTCHD1 TNN CSPG4 ARHGEF17	2.78e-05	187	84	5	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	CELSR1 FAT2 DSC3 TBL1Y PLCH2	2.78e-05	187	84	5	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFH SFMBT1 CD3D ERN1 LCK	2.85e-05	188	84	5	fe08277d5aa693a2e12786738d12ec6390e8d13d
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	UMODL1 FSD2 WDFY4 STAP1	2.91e-05	93	84	4	1a112bd4e5e63826efad0338ce99d7a7ad9c72b9
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	UMODL1 FSD2 WDFY4 STAP1	2.91e-05	93	84	4	9c566fc2a8c7630bea28e8e46df55454aa409bc1
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	UMODL1 FSD2 WDFY4 STAP1	2.91e-05	93	84	4	d102a0a015a2866e3fe549ac8796b9a0d5923d7e
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	UMODL1 FSD2 WDFY4 STAP1	2.91e-05	93	84	4	0967a93dcc72d2d8f12d56de186ec1af55c36001
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	UMODL1 FSD2 WDFY4 STAP1	2.91e-05	93	84	4	613c827a643a7b6d70ef932cfa1762e90bc5a338
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	GPC1 FAT2 DSC3 PLCH2 CD109	2.93e-05	189	84	5	533c302df467d13ab639232daf4f8cafb808260b
ToppCell	10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	UMODL1 XPNPEP2 LCK STAP1 FBXW7	2.93e-05	189	84	5	46c3f3dff71e7131a5ad1cd3b68709051a474c3c
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like\|lymph-node_spleen / Manually curated celltypes from each tissue	CFH B4GALNT1 DST ERN1 CSPG4	3.00e-05	190	84	5	0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M CFH CD3D GALM LCK	3.00e-05	190	84	5	05e6af222d0ad97cb69f399a96c9038f9dd989b9
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CFH CD3D GALM ERN1 LCK	3.00e-05	190	84	5	1634a6044dce4e026a63976031a498c7460e3dce
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CFH CD3D GALM ERN1 LCK	3.00e-05	190	84	5	08813c2f9321b82f0ec66854bb7a383aa1171780
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 DST EML5 COL14A1	3.08e-05	191	84	5	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFH SFMBT1 CD3D ERN1 LCK	3.08e-05	191	84	5	b53b490a8796e819edd3eb4a5a42b4499077b2d3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFH CD3D GALM ERN1 LCK	3.08e-05	191	84	5	9c747f8cc1cdce45e839b661d782e1e8cfb79578
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 DST EML5 COL14A1	3.08e-05	191	84	5	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M CFH PTX3 COL14A1 XPNPEP2	3.16e-05	192	84	5	a8b7c539dc3037071bf068f372e4215563e11de4
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CFH CELSR1 FAT2 DSC3 PLCH2	3.16e-05	192	84	5	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DMGDH CYP17A1 PLCH2 LRP2 XPNPEP2	3.16e-05	192	84	5	3e1a4cb0d83efd502c8613d41a1692bdda5860ed
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M CFH PTX3 COL14A1 XPNPEP2	3.16e-05	192	84	5	904c003c4f73b1dfc8243cee02aad2676c515e50
ToppCell	IPF-Lymphoid-T_Cytotoxic\|Lymphoid / Disease state, Lineage and Cell class	A2M CD3D GALM PTPRJ LCK	3.23e-05	193	84	5	3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	A2M CFH FAT4 DST COL14A1	3.23e-05	193	84	5	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	normal-na-Lymphocytic_T-T4_em\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CFH CD3D GALM ERN1 LCK	3.32e-05	194	84	5	cc413fa7d24d0c821ec3a9f6a29ad50203d4fd0d
ToppCell	BLOOD--(1)_MAIT-like_CD8_T_cells\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CFH CD3D GALM ERN1 LCK	3.32e-05	194	84	5	0064bcd9ac2fecec81f8d4e7d9f86f0089872fe7
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFH CD3D GALM ERN1 LCK	3.40e-05	195	84	5	c7b54b210cc2c8ddaefebfba74381adb2ca698b8
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CFH CD3D GALM ERN1 LCK	3.40e-05	195	84	5	e173a713d273b135db4f71bdcaada3b0e55d74f1
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFH CD3D GALM ERN1 LCK	3.40e-05	195	84	5	59164d115a0928cc9b79c7661c7190ad695f9d80
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFH CD3D GALM ERN1 LCK	3.40e-05	195	84	5	a8fd42ff6c2bd80d0e3f20fe3bbf7d113b399df1
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M CFH FAT4 TNN COL14A1	3.48e-05	196	84	5	82fad623212d986a7fca3496faf3f8c8f5b83a11
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	GPC1 FAT2 DST PLCH2 CD109	3.48e-05	196	84	5	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DMGDH CYP17A1 PLCH2 LRP2 XPNPEP2	3.48e-05	196	84	5	4ebcaac758ed01d918de9c1cd383a84457b615f3
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT2 B4GALNT1 DSC3 PLCH2 PTPRT	3.48e-05	196	84	5	a58bdf9de05d13d84211e09a933679d485bf8ab4
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-ILC\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	B4GALNT1 FSD2 MYEOV LCK STAP1	3.48e-05	196	84	5	1cc2b11764584129703ec61965e8ec4e051464e7
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M CFH FAT4 TNN COL14A1	3.48e-05	196	84	5	85e5046f774537684e1443c0fc147d562b7068d0
ToppCell	367C-Epithelial_cells-Epithelial-H_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GPC1 FAT2 DST DSC3 PLCH2	3.48e-05	196	84	5	e8db58e82300981f981402618a1befb91f6690fd
ToppCell	367C-Epithelial_cells-Epithelial-H_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GPC1 FAT2 DST DSC3 PLCH2	3.48e-05	196	84	5	2cf42b702ea15adfa6bbd86a3c9613271863f86c
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	A2M CFH CD3D TRANK1 LCK	3.57e-05	197	84	5	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	Sepsis-ICU-SEP-Myeloid-cDC1\|ICU-SEP / Disease, condition lineage and cell class	DST OBSL1 WDR41 WDFY4 DISP1	3.57e-05	197	84	5	e3174e90ea6136f1aa3a4a185b86458e35d51fd4
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CELSR1 SLC38A10 EML5 OBSL1 ST3GAL1	3.57e-05	197	84	5	1485933986921ff45669d9b7501c8d17050b3e97
Disease	response to selective serotonin reuptake inhibitor, body mass index	GPC1 PLCH2 PTPRT	1.19e-06	8	83	3	EFO_0004340, EFO_0005658
Disease	membranous glomerulonephritis (biomarker_via_orthology)	A2M CFH LRP2	7.64e-06	14	83	3	DOID:10976 (biomarker_via_orthology)
Disease	Van Maldergem Wetzburger Verloes syndrome	FAT4 DCHS1	7.82e-06	2	83	2	C1832390
Disease	Van Maldergem syndrome	FAT4 DCHS1	7.82e-06	2	83	2	cv:C1832390
Disease	Periventricular gray matter heterotopia	FAT4 DCHS1	7.82e-06	2	83	2	C1849173
Disease	Heterotopia, Periventricular, Autosomal Recessive	FAT4 DCHS1	2.34e-05	3	83	2	C1842563
Disease	sensory system disease (implicated_via_orthology)	TBL1Y TBL1XR1	2.34e-05	3	83	2	DOID:0050155 (implicated_via_orthology)
Disease	uric acid measurement	SFMBT1 VMP1 FAT4 NAA25 RAB24 LRP2 MYEOV HMGCS2 XPNPEP2	5.49e-05	610	83	9	EFO_0004761
Disease	creatinine measurement	CFH SFMBT1 DMGDH RAB24 PTPRJ CSPG4 LRP2 FSD2 ATP9B MYEOV RNF128	1.07e-04	995	83	11	EFO_0004518
Disease	pyridoxal kinase measurement	CFH HSF2BP	2.16e-04	8	83	2	EFO_0021919
Disease	tumor necrosis factor receptor superfamily member 19L measurement	CFH ARHGEF17	2.16e-04	8	83	2	EFO_0008309
Disease	Severe Combined Immunodeficiency	CD3D PRKDC	1.44e-03	20	83	2	C0085110
Disease	COVID-19 (is_implicated_in)	A2M CFH	1.59e-03	21	83	2	DOID:0080600 (is_implicated_in)
Disease	nephrosis (biomarker_via_orthology)	CFH LRP2	1.74e-03	22	83	2	DOID:2527 (biomarker_via_orthology)
Disease	heel bone mineral density, urate measurement	PRTG ST3GAL1 MYEOV WDR41	1.76e-03	182	83	4	EFO_0004531, EFO_0009270
Disease	Parkinson disease	CACNA1B PTCHD1 CYP17A1 WDR41 STAP1	2.15e-03	321	83	5	MONDO_0005180
Disease	gout	SFMBT1 NAA25 DST LRP2	2.30e-03	196	83	4	EFO_0004274
Disease	L lactate dehydrogenase measurement	CFH PTPRJ	2.43e-03	26	83	2	EFO_0004808
Disease	Squamous cell carcinoma of esophagus	FAT4 FAT2 FBXW7	2.47e-03	95	83	3	C0279626
Disease	Adenocarcinoma of large intestine	PRKDC TBL1XR1 FBXW7	2.54e-03	96	83	3	C1319315

Protein segments in the cluster

Peptide	Gene	Start	Entry
VLETWNTSVTLSGLE	UMODL1	746	Q5DID0
ITWVEGTVGTLLSDI	CD3D	41	P04234
TVVLTVVEGWATLSV	CSPG4	111	Q6UVK1
TWDVAGEVTGVTLTG	B4GALNT1	186	Q00973
TVLVTGAKWLSVLEE	AACS	376	Q86V21
IITGSSDSTVRVWDV	BTRC	356	Q9Y297
GWTVSTDVTIFVTDI	FAT4	2851	Q6V0I7
GEWTTLPVCIVEEST	CFH	676	P08603
GESVVSWSDLNIIIS	CELSR1	1696	Q9NYQ6
VLWALLTLFTVSTGE	CACNA1B	1351	Q00975
GWELNVLESVTISVA	DISP1	1031	Q96F81
TLAVLSVGTEFWVEL	CACNG6	51	Q9BXT2
IDTTCTIWGLETGQV	DCAF7	141	P61962
VAEVGVTVPDTITEW	A2M	751	P01023
SILVWSVLDGTLLTV	NWD1	1456	Q149M9
SLSTSGVLSIWDIDI	NWD2	1291	Q9ULI1
SVGDRTVTLGIWDTA	RAB24	51	Q969Q5
IIESTEEGTTEYGLW	GPR107	386	Q5VW38
EELLWVGTSAGVVLT	ARHGEF17	1931	Q96PE2
TVSEVETTGRWELGG	OBSL1	1741	O75147
TGTITTTAILDREIW	DCHS1	2226	Q96JQ0
RVTVVSTTEIGLAWS	PTPRJ	461	Q12913
ESVIGSVHTWLAEAI	GPC1	311	P35052
VKEIGLESSTVWAST	DST	3336	Q03001
EVALVQWTESVGLTL	ATP9B	591	O43861
WDSVGRLEVGTETII	HMGCS2	121	P54868
ELFAIDSESGWITTL	FAT2	2846	Q9NYQ8
SEGVIGWTQATDSIL	FKBP15	266	Q5T1M5
VAGSWLTVVTVEALG	MYEOV	256	Q96EZ4
LRSETAEGIVVVTTW	METTL16	331	Q86W50
SDVWSFGILLTEIVT	LCK	421	P06239
SSIILTETIAIDWVG	LRP2	1506	P98164
VQWTESVGLTLVGRD	ATP9A	506	O75110
TATGNITIISLIWID	OR6M1	36	Q8NGM8
SVVVWSSGVDIISHL	PHOSPHO2	221	Q8TCD6
ILGSLVVTVSAWDLD	PCDHB12	256	Q9Y5F1
VVTEGWVKAELAIST	PTPRT	141	O14522
ITAATRVGLGESSVW	PRTG	591	Q2VWP7
LTWVTEFILVGVSDD	OR8J2	6	Q8NGG1
SNWVETGLEVSLTTD	BTBD18	631	B2RXH4
VDIISWGCTITALEV	GALM	31	Q96C23
SITSWVATGFVISED	CD109	716	Q6YHK3
LVVVNDDTAWLSGLT	BABAM1	146	Q9NWV8
GWITIDEISGSIITS	DSC3	516	Q14574
LLAAWTIGISKTVTE	CPLANE1	576	Q9H799
VVTVDSESGDVLWIQ	ERN1	206	O75460
IADIVILVDGSWSIG	COL14A1	156	Q05707
GAGVETTTSVVKWTL	CYP17A1	301	P05093
SGSLDTSIRVWDVET	FBXW7	556	Q969H0
VVLLEKSELTAGSTW	DMGDH	76	Q9UI17
SVVAVEERSLTGTWD	MAN2B2	946	Q9Y2E5
IWPVIGEVTDVTASC	EML5	1186	Q05BV3
SDWGALATISTLEAV	CREG1	66	O75629
WVGLGVLVVSTVTTL	SLC38A10	381	Q9HBR0
GVAVSWLTGAIAVLE	NHLRC1	266	Q6VVB1
GLITLSDWAAAVESV	PPEF2	586	O14830
TSLWVNGELAATTVE	PTX3	281	P26022
TVSWVTGCLTALLET	OR2K2	146	Q8NGT1
LTVVLATWTIGIGVS	OPN1SW	151	P03999
LWGVSSSEEVVKAIL	HSF2BP	131	O75031
WVGDSTGVILVLTTF	SORT1	116	Q99523
WITLTVVSVEFGVIG	PTCHD1	726	Q96NR3
WLTISEDGLTAVRSE	FSD2	576	A1L4K1
WIETISSVSVVGDVL	SLITRK3	576	O94933
VSEESEAWILAVATG	SLC39A4	581	Q6P5W5
TGVNRTVWELSEEGV	RNF128	56	Q8TEB7
TIDLEWVVSAITTGT	ST3GAL1	211	Q11201
VVHGVESLVELLGWT	SIRT3	366	Q9NTG7
TTVIESDLGVWSSRA	SLC35E2A	61	P0CK97
ILSAGVDKTTIIWDA	TBL1XR1	281	Q9BZK7
LATTDLAVLGTAWVT	TNN	346	Q9UQP3
EVLLWVGGSVVLSSE	PLCH2	21	O75038
TESGEEWRGFILTVT	STAP1	106	Q9ULZ2
AGSWVERSTEGVDIV	WDFY4	1666	Q6ZS81
TTVIESDLGVWSSRA	SLC35E2B	61	P0CK96
VLSAGVDKTTIIWDA	TBL1Y	291	Q9BQ87
VVEIVATILSWTGLA	PRKDC	2186	P78527
SLSTWIVTVVENIGG	SFMBT1	176	Q9UHJ3
VSITTNLVDLVWGSE	XPNPEP2	181	O43895
VQWLISIGASVETIG	TRANK1	186	O15050
ILTASADRTVIVWDG	WDR41	106	Q9HAD4
ASVEEAISSGTWVDI	UFL1	311	O94874
EEGTEGTISLWSIIS	VMP1	171	Q96GC9
ETGDETTVWQALTLL	NAA25	481	Q14CX7
TTVWQALTLLEEGLT	NAA25	486	Q14CX7
VGLISVVTESWRLSL	GRIN2C	271	Q14957